What is the cheapest price for IVF in China? Analysis of the minimum cost standards for domestic IVF

Content begins

The cost of domestic IVF is one of the most concerning issues for people planning to undergo assisted reproductive treatment. To answer directly: In China, the minimum cost for a complete IVF cycle can be controlled within the range of 20,000 to 30,000 RMB, corresponding to the first-generation IVF (IVF) technical protocol in public hospitals, using domestically produced ovulation stimulation medications. However, actual expenses can fluctuate significantly due to hospital level, region, technical protocol, medication choice, and individual circumstances.

Core factors affecting IVF costs

The final cost of IVF is not fixed; the following variables directly impact the total expense:

• Technical protocol: First-generation IVF (IVF) costs about 20,000-30,000 RMB, second-generation IVF (ICSI) about 30,000-50,000 RMB, and third-generation IVF (PGT) about 50,000-80,000 RMB. The more complex the technology, the higher the cost.
• Choice of ovulation stimulation medication: Domestic medications (e.g., Lishenbao, urinary gonadotropins) cost about 5,000-8,000 RMB per cycle, while imported medications (e.g., Gonal-f, Pergoveris) cost about 12,000-20,000 RMB, showing a significant price difference.
• Hospital level and region: Tertiary hospitals in first-tier cities charge higher fees than those in second- and third-tier cities; private fertility centers typically cost 30% to 80% more than public hospitals.
• Individual ovarian response: People with normal ovarian function require lower medication doses and shorter cycles; those with diminished ovarian reserve (low AMH, high FSH) may need higher doses of ovulation stimulation medications, increasing costs.
• Need for additional surgeries: Procedures such as hysteroscopy, endometrial polyp removal, or hydrosalpinx treatment can add 3,000 to 15,000 RMB.
• Embryo freezing and subsequent transfers: If the first transfer is unsuccessful, frozen embryo transfer costs about 3,000 to 6,000 RMB per cycle (excluding thawing and endometrial preparation costs).

Differences in fee standards among different hospitals

There are significant differences in fee structures and total amounts between public tertiary hospitals and private fertility centers. The following is a typical comparison (complete cycle, first-generation IVF):

It is important to note that fee standards for different hospitals in the same city may differ by 10,000 to 20,000 RMB. It is recommended to obtain detailed cost lists from 2-3 hospitals for comparison before making a decision.

Balancing cost and effectiveness in the eyes of reproductive doctors

From a clinical perspective, cost is not the only indicator for choosing an IVF protocol. The following is a general consensus among doctors:

• People suitable for low-cost protocols: Age <35 years, normal ovarian function (AMH ≥2 ng/mL, antral follicle count ≥10), no complex infertility factors, first IVF attempt. For these individuals, using domestic ovulation stimulation medications and first-generation IVF has no significant difference in success rates compared to high-cost protocols.
• People not suitable for simply pursuing low cost: Advanced age (≥38 years), diminished ovarian reserve (AMH <1.2 ng/mL), previous IVF failure history, genetic diseases requiring third-generation IVF. For these individuals, excessive cost-cutting may reduce the success rate per cycle, ultimately increasing total expenses.
• Doctor's advice: Cost planning should aim for "achieving a healthy live birth" rather than "minimum cost per cycle." It is not advisable to over-save on key aspects such as embryo culture and laboratory conditions.

Five most easily overlooked cost details

Many people only focus on the "package price" during initial consultation. The following details are often overlooked but can lead to significant additional expenses:

1. Validity of preoperative tests: Some test results (e.g., chromosome karyotype, blood type, infectious disease screening) are valid for life, but semen analysis, hormone panel, AMH, and ultrasound results are typically valid for 3-6 months. If the cycle is delayed after testing, retesting may be required, adding 500 to 2,000 RMB.
2. Embryo freezing fees are charged annually: Remaining embryos after the first transfer need to be frozen and stored, costing about 1,000 to 3,000 RMB per year. If used years later, the cumulative cost can be substantial.
3. Luteal phase support medications after transfer: Progesterone (injections, gel, or oral) is needed for about 10-12 weeks after transfer, costing about 500 to 2,000 RMB. This is usually not included in the cycle package.
4. Male partner tests are easily missed: Semen analysis, sperm DNA fragmentation rate, chromosome tests, etc., cost about 1,000 to 3,000 RMB. Some hospitals require the male partner to register separately.
5. Costs for managing complications: Conditions such as ovarian hyperstimulation syndrome (OHSS), intrauterine fluid, or infections require additional treatment, and severe cases may require hospitalization, costing 5,000 to 20,000 RMB.

People suitable and unsuitable for "low-cost IVF protocols"

People suitable for low-cost protocols (domestic medications + first-generation IVF + public hospitals)

• Age ≤35 years, normal ovarian reserve (AMH ≥2.0, FSH <8)
• Clear and simple cause of infertility (e.g., mild male oligoasthenospermia, female tubal patency issues)
• First assisted reproductive treatment, no previous failure history
• No genetic diseases or chromosomal abnormalities requiring PGT
• Limited financial budget and willing to accept a slightly lower per-cycle success rate (about 40% to 50%)

People not suitable for simply pursuing low cost

• Age ≥38 years, or diminished ovarian reserve (AMH <1.2)
• History of 2 or more previous IVF failures
• Need for third-generation IVF (PGT) for genetic screening
• Complex uterine issues (e.g., adenomyosis, intrauterine adhesions, recurrent implantation failure)
• Very poor sperm quality in the male partner (e.g., severe oligoasthenospermia, azoospermia requiring testicular biopsy)

Frequently asked questions about IVF costs

Below are the most common cost-related questions asked during patient education at fertility centers:

• Q: Can medical insurance cover IVF costs?
  A: Currently, domestic IVF costs (including tests, ovulation stimulation, egg retrieval, transfer, etc.) are not yet included in the national medical insurance pooling payment. Some cities (e.g., Beijing) have included some assisted reproductive items in the personal medical insurance account payment scope, but the reimbursement ratio and items are limited. Specific conditions need to be confirmed with local medical insurance policies and hospitals.
• Q: Why is third-generation IVF so much more expensive than first-generation?
  A: Third-generation IVF (PGT) adds embryo biopsy and genetic testing (gene chip or sequencing) on top of first/second-generation. The cost per embryo tested is about 3,000 to 6,000 RMB, plus the investment in technology equipment and laboratory costs, the total cost is naturally higher.
• Q: Can costs be paid in installments or through loans?
  A: Some private fertility centers cooperate with financial institutions to offer installment payment plans, while public hospitals usually do not support this. It is recommended to confirm with the hospital's financial department in advance.
• Q: How long do tests take? How long does the entire process take?
  A: Preoperative tests for both partners take about 2-4 weeks (some items need to be done at specific times during the menstrual cycle). After all test results are available, the doctor formulates a protocol, and entering the ovulation stimulation cycle takes about 1-2 months. From the initial consultation to the end of the transfer, a complete cycle typically takes 3-6 months.
• Q: Can I still do IVF with low AMH? Will it be more expensive?
  A: Low AMH indicates diminished ovarian reserve, but it is still possible to try. Costs are usually higher because higher doses of ovulation stimulation medications may be needed, and multiple egg retrievals may be required to accumulate embryos. The total cost can be 1.5 to 3 times that of a standard protocol.

Practitioner observation: Cost misconceptions and rational choices

Having worked in the field of assisted reproduction for many years, I have observed several common cognitive biases regarding costs:

• Misconception 1: The cheapest protocol is the most cost-effective. Fact: The success rate per cycle is directly related to age, ovarian function, and laboratory conditions. If cost-cutting leads to first transfer failure, the subsequent cumulative costs often exceed a well-planned, reasonable protocol.
• Misconception 2: Private hospitals are always much more expensive than public ones. Fact: Private hospitals have advantages in service experience, waiting time, and medication flexibility. The "basic package" price at some private hospitals is not significantly different from public hospitals, but mid-to-high-end packages are indeed more expensive.
• Misconception 3: Imported ovulation stimulation medications are always better than domestic ones. Fact: Domestic gonadotropins (e.g., Lishenbao) and imported medications (e.g., Gonal-f) show no significant difference in clinical pregnancy rates. The differences mainly lie in purity and injection experience. For young people with normal ovarian function, domestic medications are a cost-effective choice.
• Observation: More and more patients are beginning to focus on "total cost per live birth" rather than "cost per cycle," which is a rational trend. It is recommended to clearly communicate your budget range to the doctor during the initial consultation, so the doctor can develop a more matching protocol.

Core examinations and treatment entities covered in this article: AMH, FSH, LH, antral follicle count, semen analysis, chromosome testing, genetic counseling, hysteroscopy, ovulation induction, egg retrieval, embryo culture, PGT, frozen embryo transfer, luteal phase support, reproductive doctor, laboratory.

• AMH test
• FSH/LH
• Antral follicle count
• Semen analysis
• Chromosome karyotype
• Hysteroscopy
• Ovulation induction protocol
• Egg retrieval surgery
• Embryo culture
• PGT-A
• Frozen embryo transfer
• Luteal phase support
• Domestic ovulation stimulation medications
• Imported ovulation stimulation medications